Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Other Non Operating Income came in at -$360000.0 in Q3 2025, down 1736.36% year-on-year from $22000.0 in Q3 2024, and down 1100.0% quarter-over-quarter from -$30000.0 in Q2 2025.
Dianthus Therapeutics (DNTH) Other Non Operating Income (2022 - 2025) Analysis & Trends
Dianthus Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$360000.0 for Q3 2025.
- On a quarterly basis, Other Non Operating Income fell 1736.36% year-over-year to -$360000.0 in Q3 2025; TTM through Sep 2025 was -$304000.0, a 40.74% decrease from a year earlier, with the FY2024 full-year figure at -$64000.0, up 24.71% from the prior year.
- Other Non Operating Income fell to -$360000.0 in Q3 2025 per DNTH's latest filing, from -$30000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $108000.0 in Q4 2024 and bottomed at -$360000.0 in Q3 2025.
- The 4-year median for Other Non Operating Income is -$23000.0 (2023), against an average of -$42153.8.
- Biggest YoY gain for Other Non Operating Income was 345.45% in 2024; the steepest drop was 3700.0% in 2024.
- Year by year, Other Non Operating Income stood at -$43000.0 in 2022, then dropped by 2.33% to -$44000.0 in 2023, then jumped by 345.45% to $108000.0 in 2024, then slumped by 433.33% to -$360000.0 in 2025.
- Per Business Quant, the three latest DNTH Other Non Operating Income figures stand at -$360000.0 (Q3 2025), -$30000.0 (Q2 2025), and -$22000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -360,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | -80,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Dec 31, 2023 | -44,000.00 |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -23,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Dec 31, 2022 | -43,000.00 |
| Sep 30, 2022 | 56,000.00 |